Moreover, low-dose IL-2 has been used to treat systemic lupus erythematosus (SLE), type 1 diabetes (T1D), and other autoimmune diseases and has shown some efficacy [8, 9]. Here, IL2 is linked to type 1 diabetes mellitus.